Subscribe to RSS Feed RSS Feed
 

Food & Drug Administration 

Food & Drug Administration Logo

WILL FDA COME OUT OF ITS CAVE?

Cat.: Food & Drug Administration, Once in a Lifetime
06. November 2008
Comment

The election of Barack Obama and Democratic gains in Congress might get the Food and Drug Administration out of the stone age. Democrats in Congress have spent the past year battling with the Bush administration for FDA budget increases. The agency simply doesn't have the staff scientists, modern technology or ...

DID FDA LOOK AWAY ON DANGERS OF CHEMICAL COMPOUND?

Cat.: Food & Drug Administration, Once in a Lifetime
30. October 2008
Comment

The New York Times' Tara Parker-Pope reports that a scientific advisory panel unloaded on the Food and Drug Administration in a report that concerns their regulation of bisphenol-A. FDA ignored a series of studies that warned of the dangers of bisphenol-A, a chemical found in baby bottles, water bottles, ...

MEDICAL DEVICES NOT FULLY VETTED

Cat.: Food & Drug Administration, Once in a Lifetime
27. October 2008
Comment

The New York Times' Reed Abelson reports on the Food and Drug Administration's "quick-review" process for approving new medical devices that the FDA deems as similar to pre-existing devices on the market. The rule was designed when medical devices were first regulated ...

TO IMPROVE PR, FDA GAVE CROOKED CONTRACT TO PR FIRM

Cat.: Food & Drug Administration, Once in a Lifetime
02. October 2008
Comment

The Washington Post's Robert O'Harrow gives us a cut-and-dried tale of corruption -- highly ironic corruption -- at the Food and Drug Administration.

As Understanding Government has detailed, lawmakers have held hearings and newspapers have run stories screaming that the FDA wasn't doing ...

FDA AND THE PRE-EMPTION PRINCIPLE

Cat.: Food & Drug Administration, Once in a Lifetime
19. September 2008
Comment

The New York Times' Adam Liptak explains today the upcoming Supreme Court case of Wyeth v. Levine. Diana Levine had her right arm amputated after using a nausea drug from the pharmaceutical company Wyeth. The drug horrifically gave her gangrene and ...

GIVE THE FDA MORE MONEY!!! TOBACCO EDITION

Cat.: Food & Drug Administration, Once in a Lifetime
31. July 2008
Comment

The Washington Post's Rob Stein at first appears to be writing an unassuming piece about how the House overwhelmingly voted to let the Food and Drug Administration regulate tobacco products. But in the last few paragraphs, there's a ...

HERE’S A THOUGHT: GIVE FDA MORE MONEY

Cat.: Food & Drug Administration, Once in a Lifetime
30. July 2008
Comment

Understanding Government has taken some time off from writing about how the Food and Drug Administration needs more money. But we're back on the FDA/more cash beat today thanks to the Wall Street Journal's Alicia Mundy.

Mundy reports on the efforts for broad agency reforms proposed by Sen. Charles Grassely ...

FEDS DETAIN JALAPENO PEPPER IN TEXAS

Cat.: Centers for Disease Control, Food & Drug Administration, Once in a Lifetime
22. July 2008
Comment

The Washington Post's Annys Shin reports that the Food and Drug Administration found a jalapeno pepper in McAllen, Texas that has bacteria which can cause salmonella. The contaminated pepper was made in Mexico and sold by the small Texas company, Agricola Zaragosa. In May, the FDA warned that ...

TAINTED TOMATOES KEEP FDA IN PICKLE

Cat.: Food & Drug Administration, Once in a Lifetime
01. July 2008
Comment

The Wall Street Journal's Jane Zhang, Julie Jargon, and A.J. Miranda join forces for a look at the Food and Drug Administration's failure to trace the origin of a salmonella outbreak. The outbreak has sickened 810 people over the past month, ...

COUNTERPOINT: THE FDA IS TOO CONCERNED ABOUT SAFETY

Cat.: Food & Drug Administration, Once in a Lifetime
30. June 2008
Comment

That's the message today from the Wall Street Journal's Avery Johnson and Ron Winslow. The reporters document grousing of pharmaceutical executives who say the oft-criticized Food and Drug Administration has been overly cautious in approving prescription drugs for the market.

They might just ...